Toll-like receptor 4 mediates retinal ischemia/reperfusion injury through nuclear factor-κB and spleen tyrosine kinase activation

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5807-5816

  Ishizuka, Fumiya ^a   Shimazawa, Masamitsu ^a   Inoue, Yuki ^a   Nakano, Yusuke ^a   Ogishima, Hiromi ^a   Nakamura, Shinsuke ^a   Tsuruma, Kazuhiro ^a   Tanaka, Hiroyuki ^a   Inagaki, Naoki ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Nuclear factor B; Piceatannol; Spleen tyrosine kinase; Toll like receptor 4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PICEATANNOL; PROTEIN C JUN; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA ISCHEMIA; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING;

NUCLEAR FACTOR-ΚB; PICEATANNOL; SPLEEN TYROSINE KINASE; TOLL-LIKE RECEPTOR 4;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; REPERFUSION INJURY; RETINAL DISEASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84883214806     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-11932     Document Type: Article

References (26)

1. Ogishima H, Nakamura S, Nakanishi T, et al. Ligation of the pterygopalatine and external carotid arteries induces ischemic damage in the murine retina. Invest Ophthalmol Vis Sci. 2011; 52:9710-9720.
2. Akira S. TLR signaling. Curr Top Microbiol Immunol. 2006; 311:1-16.
3. Hyakkoku K, Hamanaka J, Tsuruma K, et al. Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience. 2010;171:258-267.
4. Suzuki Y, Hattori K, Hamanaka J, et al. Pharmacological inhibition of TLR4-NOX4 signal protects against neuronal death in transient focal ischemia. Sci Rep. 2012;2:896.
5. Luo C, Yang X, Kain AD, Powell DW, Kuehn MH, Tezel G. Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Invest Ophthalmol Vis Sci. 2010;51:5697-5707.
6. Yi H, Patel AK, Sodhi CP, Hackam DJ, Hackam AS. Novel role for the innate immune receptor Toll-like receptor 4 (TLR4) in the regulation of the Wnt signaling pathway and photoreceptor apoptosis. PLoS One. 2012;7:e36560.
7. Dvoriantchikova G, Barakat DJ, Hernandez E, Shestopalov VI, Ivanov D. Toll-like receptor 4 contributes to retinal ischemia/ reperfusion injury. Mol Vis. 2010;16:1907-1912.
8. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999;162:3749-3752.
9. Ishizuka F, Shimazawa M, Umigai N, et al. Crocetin, a carotenoid derivative, inhibits retinal ischemic damage in mice. Eur J Pharmacol. 2013;703:1-10.
10. Imai S, Inokuchi Y, Nakamura S, Tsuruma K, Shimazawa M, Hara H. Systemic administration of a free radical scavenger, edaravone, protects against light-induced photoreceptor degeneration in the mouse retina. Eur J Pharmacol. 2010; 642:77-85.
11. Caso JR, Pradillo JM, Hurtado O, Leza JC, Moro MA, Lizasoain I. Toll-like receptor 4 is involved in subacute stress-induced neuroinflammation and in the worsening of experimental stroke. Stroke. 2008;39:1314-1320.
12. Qiao H, Zhang X, Zhu C, et al. Luteolin downregulates TLR4, TLR5, NF-kappaB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Res. 2012;1448:71-81.
13. Whiteside ST, Epinat JC, Rice NR, Israel A. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-κB activity. Embo J. 1997;16:1413-1426.
14. Wu H, Arron JR. TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology. Bioessays. 2003;25:1096-1105.
15. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem. 2001;276: 18934-18940.
16. Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13: 816-825.
17. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326-1331.
18. Miller YI, Choi SH, Wiesner P, Bae YS. The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL. Br J Pharmacol. 2012;167:990-999.
19. Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, Worthen GS. Lipopolysaccharide-induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways. J Biol Chem. 2004;279: 10883-10891.
20. Chaudhary A, Fresquez TM, Naranjo MJ. Tyrosine kinase Syk associates with toll-like receptor 4 and regulates signaling in human monocytic cells. Immunol Cell Biol. 2007;85:249-256.
21. Bae YS, Lee JH, Choi SH, et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4-and spleen tyrosine kinasedependent activation of NADPH oxidase 2. Circ Res. 2009; 104:210-218.
22. Lu R, Pan H, Shively JE. CEACAM1 negatively regulates IL-1beta production in LPS activated neutrophils by recruiting SHP-1 to a SYK-TLR4-CEACAM1 complex. PLoS Pathog. 2012;8: e1002597.
23. Pamuk ON, Lapchak PH, Rani P, Pine P, Dalle Lucca JJ, Tsokos GC. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol. 2010;299:G391-G399.
24. Raeder EM, Mansfield PJ, Hinkovska-Galcheva V, Shayman JA, Boxer LA. Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis. J Immunol. 1999;163:6785-6793.
25. Yu T, Lee YJ, Jang HJ, et al. Anti-inflammatory activity of Sorbus commixta water extract and its molecular inhibitory mechanism. J Ethnopharmacol. 2011;134:493-500.
26. Islam S, Hassan F, Mu MM, et al. Piceatannol prevents lipopolysaccharide (LPS)-induced nitric oxide (NO) production and nuclear factor (NF)-κB activation by inhibiting IκB kinase (IKK). Microbiol Immunol. 2004;48:729-736.